ADAM17 anticorps (ADAM Metallopeptidase Domain 17) (C-Term)

Details for Product anti-ADAM17 Antibody No. ABIN1030720
Antigène
  • ADAM18
  • CD156B
  • CSVP
  • NISBD
  • TACE
  • CD156b
  • Tace
  • adam17
  • si:dkey-81b15.2
  • adam18
  • cd156b
  • csvp
  • tace
  • fc20b01
  • wu:fc20b01
  • zgc:63886
  • ADAM metallopeptidase domain 17
  • a disintegrin and metallopeptidase domain 17
  • ADAM metallopeptidase domain 17b
  • ADAM metallopeptidase domain 17 L homeolog
  • ADAM metallopeptidase domain 17a
  • ADAM17
  • Adam17
  • adam17b
  • adam17.L
  • adam17a
Épitope
C-Term
62
19
16
11
10
9
8
8
7
6
4
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
Reactivité
Humain, Souris, Rat (Rattus)
243
95
86
2
2
1
1
1
1
1
Hôte
Lapin
207
22
21
2
1
Clonalité
Polyclonal
Conjugué
Cet anticorp ADAM17 est non-conjugé
14
10
7
6
6
5
4
4
4
4
4
4
1
1
1
1
1
1
Application
Immunocytochemistry (ICC), Flow Cytometry (FACS), Immunofluorescence (IF), ELISA, Western Blotting (WB)
195
120
45
38
25
14
10
10
10
7
5
3
2
1
1
1
Options
Blocking Peptide Blocking peptide for this product available: ABIN1381978
Specificité 80 to 130 kDa bands can be detected, which may represent mature protein, precursor, and glycosylated TACE.
Purification Affinity chromatography purified via peptide column
Plasmids, Primers & others Plasmids, Primers & others ADAM17 products on genomics-online (e.g. as negative or positive controls)
Antigène
Autre désignation TACE (ADAM17 Antibody Extrait)
Poids moléculaire Predicted: 93 kDa
Pathways Signalisation Notch, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Response to Growth Hormone Stimulus
Indications d'application TACE antibody can be used for detection of TACE by Western blot at 0.5 - 1 μg/mL. For immunocytochemistry use 10 μg/mL.
Restrictions For Research Use only
Format Liquid
Buffer PBS
Agent conservateur Sodium azide
Précaution d'utilisation This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock 4 °C
Images (Fournisseur)
Western Blotting (WB) image for anti-ADAM Metallopeptidase Domain 17 (ADAM17) (C-Term) antibody (ABIN1030720) anti-ADAM Metallopeptidase Domain 17 (ADAM17) (C-Term) antibody
Immunohistochemistry (IHC) image for anti-ADAM Metallopeptidase Domain 17 (ADAM17) (C-Term) antibody (ABIN1030720) anti-ADAM Metallopeptidase Domain 17 (ADAM17) (C-Term) antibody (Image 2)
Produit citée dans: McGowan, Mullooly, Caiazza, Sukor, Madden, Maguire, Pierce, McDermott, Crown, ODonovan, Duffy: "ADAM-17: a novel therapeutic target for triple negative breast cancer." dans: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 24, Issue 2, pp. 362-9, 2013 (PubMed).

Avez-vous cherché autre chose?